Which of the following requires a separate DEA registration?

A separate DEA registration is required for each specific activity involving controlled substances because these activities have different regulatory requirements and implications. When a pharmacy, practitioner, or facility engages in prescribing, research, or manufacturing controlled substances, each of these activities is treated distinctly by the Drug Enforcement Administration (DEA).

Prescribing controlled substances generally requires a DEA registration for practitioners authorized to prescribe such medications. However, merely having this registration does not cover additional activities such as research or manufacturing.

Conducting research on controlled substances necessitates a separate registration, as researchers need to comply with specific guidelines and protocols set by the DEA for handling, storing, and transporting controlled substances used in research activities.

Manufacturing controlled substances distinctly requires its own DEA registration due to the complexities and regulatory oversight associated with producing medications.

All these activities pertain to the interaction with controlled substances, each requiring a clear delineation in registration to ensure compliance with federal laws. By holding separate registrations, the DEA can maintain better control and monitoring over each activity, mitigating the risk of misuse and ensuring public safety. This multifaceted approach allows for better tracking, accountability, and regulatory compliance within the pharmaceutical industry.